Close
Patheon

News Releases

  • 22 Aug 2017
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V., a public limited liability company (naamloze vennootschap) organized under the laws of The Netherlands (NYSE: PTHN) (“Patheon”), today announced that it has submitted written notice to the New York Stock Exchange (the “NYSE”) of its intention to voluntarily delist its ordinary shares, par value €0.01 per share (the “Shares”), from the NYSE. The voluntary delisting is subject to and conditioned upon (1) the initial expiration of themore...
  • 08 Jun 2017

    Highlights:

    • 2Q 2017 revenue of $483 million
    • Net income from continuing operations of $28 million
      • Net income from continuing operations per diluted share of $0.19
    • 2Q 2017 Adjusted EBITDA of $94 million
    • Adjusted net income from continuing operations of $29 million
      • Adjusted net income from continuing operations per diluted share of $0.20
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of pharmaceutical development and manufacturing services, today reported financial results for the quarter ended April 30, 2017. Second quarter 2017 revenue was $483 million, compared to $469 million in the prior-year period, and second quarter 2017 adjusted EBITDA was $94 million, compared to $98 million in the prior-year period. Revenue for the first six months of fiscal 2017 was $more...
  • 16 Mar 2017

    Highlights:

    • 1Q 2017 revenue increased by 13% year-over-year to $457M
    • Net income from continuing operations was $28M
      • Net income from continuing operations per diluted share was $0.19
    • 1Q 2017 Adjusted EBITDA was $83M, or 18% of revenue, a 350 bp year-over-year improvement
    • Adjusted net income from continuing operations was $21M
      • Adjusted net income from continuing operations per diluted share was $0.14
    • Updated financial outlook for fiscal year 2017
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of pharmaceutical development and manufacturing services, today reported financial results for the quarter ended January 31, 2017. First quarter 2017 revenue was $457 million, an increase of 13% compared to the first quarter of 2016. Adjusted EBITDA in the first quarter was $83 million, 40% higher than the prior-year period. Adjusted EBITDA margin as a percentage of revenue was 18%,more...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com